Resveratrol rescues kidney mitochondrial function following hemorrhagic shock

Shock

Volumn 44, Issue 2, 2015, Pages 173-180

  Hao, Wang ^a,b   Guan, Yuxia ^b,c   Karamercan, Mehmet Akif ^b,d   Ye, Lan ^c   Bhatti, Tricia ^e   Becker, Lance B ^c   Baur, Joseph A ^c   Sims, Carrie A ^b,c  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Hemorrhagic shock; Kidney; Mitochondria; Oxidative stress; Resuscitation; Resveratrol

Indexed keywords

4 HYDROXYNONENAL; CATALASE; CREATININE; LACTIC ACID; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REACTIVE OXYGEN METABOLITE; RESVERATROL; RINGER LACTATE SOLUTION; SIRTUIN 1; 3-NITROTYROSINE; 4-HYDROXY-2-NONENAL; ALDEHYDE; ANTIOXIDANT; CITRATE SYNTHASE; STILBENE DERIVATIVE; TYROSINE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; BIOGENESIS; BLOOD PH; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FLUOROMETRY; HEMORRHAGIC SHOCK; KIDNEY FUNCTION; KIDNEY MITOCHONDRIAL FUNCTION; LIPID PEROXIDATION; MALE; MITOCHONDRION; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; RESPIROMETRY; RESUSCITATION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ACUTE KIDNEY INJURY; AGING; ANALOGS AND DERIVATIVES; ANIMAL; BLEEDING; CHEMISTRY; KIDNEY; LONG EVANS RAT; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY;

ACUTE KIDNEY INJURY; AGING; ALDEHYDES; ANIMALS; ANTIOXIDANTS; CITRATE (SI)-SYNTHASE; HEMORRHAGE; KIDNEY; MALE; MITOCHONDRIA; OXIDATIVE STRESS; RATS; RATS, LONG-EVANS; REACTIVE OXYGEN SPECIES; RESUSCITATION; SHOCK, HEMORRHAGIC; STILBENES; TYROSINE;

EID: 84942592161     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000390     Document Type: Article

References (39)

1. Minei JP, Cuschieri J, Sperry J, Moore EE, West MA, Harbrecht BG, O-Keefe GE, Cohen MJ, Moldawer LL, Tompkins RG, et al.: The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock. Crit Care Med 40(4):1129-1135, 2012.
2. Evans RG, Gardiner BS, Smith DW, O-Connor PM: Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis. Am J Physiol Renal Physiol 295(5):F1259YF1270, 2008.
3. Benns M, Carr B, Kallan MJ, Sims CA: Benchmarking the incidence of organ failure after injury at trauma centers and nontrauma centers in the United States. J Trauma Acute Care Surg 75(3):426-431, 2013.
4. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16(11):3365-3370, 2005.
5. Kozlov AV, Bahrami S, Calzia E, Dungel P, Gille L, Kuznetsov AV, Troppmair J: Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure Ann Intensive Care 1(1):41, 2011.
6. Karamercan MA, Weiss SL, Villarroel JP, Guan Y, Werlin E, Figueredo R, Becker LB, Sims C: Can peripheral blood mononuclear cells be used as a proxy for mitochondrial dysfunction in vital organs during hemorrhagic shock and resuscitation? Shock 40(6):476-484, 2013.
7. Skripchenko A, Myrup A, Thompson-Montgomery D, Awatefe H, Moroff G, Wagner SJ: Periods without agitation diminish platelet mitochondrial function during storage. Transfusion 50(2):390-399, 2010.
8. Cairns CB: Rude unhinging of the machinery of life: metabolic approaches to hemorrhagic shock. Curr Opin Crit Care 7(6):437-443, 2001.
9. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, et al.: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127(6):1109-1122, 2006.
10. Lopez-Lluch G, Irusta PM, Navas P, de Cabo R: Mitochondrial biogenesis and healthy aging. Exp Gerontol 43(9):813-819, 2008.
11. Baur JA, Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5(6):493-506, 2006.
12. Scarpulla RC: Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta 1813(7):1269-1278, 2011.
13. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, et al.: Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127(2): 397-408, 2006.
14. Tsai YF, Liu FC, Lau YT, Yu HP: Role of Akt-dependent pathway in resveratrol-mediated cardioprotection after trauma-hemorrhage. J Surg Res 176(1):171-177, 2012.
15. Yu HP, Yang SC, Lau YT, Hwang TL: Role of Akt-dependent up-regulation of hemeoxygenase-1 in resveratrol-mediated attenuation of hepatic injury after trauma hemorrhage. Surgery 148(1):103-109, 2010.
16. SoubaW,Wilmore D: Shock models: hemorrhage. In Ayala A, Wang P, Chaudry I, (eds.): Surgical Research. San Diego, CA: Academic Press, pp 325-327, 2001.
17. Smeding L, Leong-Poi H, Hu P, Shan Y, Haitsma JJ, Horvath E, Furmli S, Masoom H, Kuiper JW, Slutsky AS, et al.: Salutary effect of resveratrol on sepsis-induced myocardial depression. Crit Care Med 40(6):1896-1907, 2012.
18. Palmeira CM, Moreno AJ: High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. In Pesta D, Gnaiger E, (eds.): Mitochondrial Bioenergetics: Methods and Protocols. New York, NY: Humana Press, pp 25-58, 2012.
19. Kuznetsov AV, Veksler V, Gellerich FN, Saks V, Margreiter R, Kunz WS: Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat Protoc 3(6):965-976, 2008.
20. Supale S, Thorel F, Merkwirth C, Gjinovci A, Herrera PL, Scorrano L, Meda P, Langer T, Maechler P: Loss of prohibitin induces mitochondrial damages altering beta-cell function and survival and is responsible for gradual diabetes development. Diabetes 62(10):3488-3499, 2013.
21. Liu H, Yu S, Xu W, Xu J: Enhancement of 26S proteasome functionality connects oxidative stress and vascular endothelial inflammatory response in diabetes mellitus. Arterioscler Thromb Vasc Biol 32(9):2131-2140, 2012.
22. Mattiasson G: Analysis of mitochondrial generation and release of reactive oxygen species. Cytometry A 62(2):89-96, 2004.
23. Srere PA, Matsuoka Y: Inhibition of rat citrate synthase by acetoacetyl CoA and NADH. Biochem Med 6(3):262-266, 1972.
24. Lee JS, Park AH, Lee SH, Kim JH, Yang SJ, Yeom YI, Kwak TH, Lee D, Lee SJ, Lee CH, et al.: Beta-lapachone, a modulator of NAD metabolism, prevents health declines in aged mice. PLoS One 7(10):e47122, 2012.
25. Dyess DL, Powell RW, Swafford AN Jr., Schmacht DC, RobertsWS, Ferrara JJ, Ardell JL: Redistribution of organ blood flow after hemorrhage and resuscitation in full-term piglets. J Pediatr Surg 29(8):1097-1102, 1994.
26. Parke AL, Liu PT, Parke DV: Multiple organ dysfunction syndrome. Inflammopharmacology 11(1):87-95, 2003.
27. Spahn DR, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Gordini G, Stahel PF, Hunt BJ, Komadina R, Neugebauer E, et al.: Management of bleeding following major trauma: a European guideline. Crit Care 11(1):R17, 2007.
28. Aksu U, Bezemer R, Yavuz B, Kandil A, Demirci C, Ince C: Balanced vs unbalanced crystalloid resuscitation in a near-fatal model of hemorrhagic shock and the effects on renal oxygenation, oxidative stress, and inflammation. Resuscitation 83(6):767-773, 2012.
29. Kolgazi M, Sener G, Cetinel S, Gedik N, Alican I: Resveratrol reduces renal and lung injury caused by sepsis in rats. J Surg Res 134(2):315-321, 2006.
30. Li T, Zhang J, Feng J, Li Q, Wu L, Ye Q, Sun J, Lin Y, Zhang M, Huang R, et al.: Resveratrol reduces acute lung injury in a LPS induced sepsis mouse model via activation of SIRT1. Mol Med Rep 7(6):1889-1895, 2013.
31. Hjortrup PB, Haase N, Wetterslev M, Perner A: Clinical review: predictive value of neutrophil gelatinase-Associated lipocalin for acute kidney injury in intensive care patients. Crit Care 17(2):211, 2013.
32. Cruz DN, de Cal M, Garzotto F, Perazella MA, Lentini P, Corradi V, Piccinni P, Ronco C: Plasma neutrophil gelatinase-Associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 36(3):444-451, 2010.
33. Ungvari Z, Sonntag WE, de Cabo R, Baur JA, Csiszar A: Mitochondrial protection by resveratrol. Exerc Sport Sci Rev 39(3):128-132, 2011.
34. Xu Y, Nie L, Yin YG, Tang JL, Zhou JY, Li DD, Zhou SW: Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in ratmesangial cells. Toxicol Appl Pharmacol 259(3):395-401, 2012.
35. Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G, Pearson K, de Cabo R, Pacher P, Zhang C, et al.: Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 297(1):H13YH20, 2009.
36. Musatov A, Carroll CA, Liu YC, Henderson GI, Weintraub ST, Robinson NC: Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochemistry 41(25):8212-8220, 2002.
37. Chen J, Henderson GI, Freeman GL: Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J Mol Cell Cardiol 33(11):1919-1927, 2001.
38. Rodgers JT, Lerin C, Gerhart-Hines Z, Puigserver P: Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett 582(1):46-53, 2008.
39. Sack MN, Finkel T: Mitochondrial metabolism, sirtuins, and aging. Cold Spring Harb Perspect Biol 4(12), 2012.